Tagged with EDA

Singapore Takeda’s President of Emerging Markets Business Unit, Giles Platford, speaks about his assignments across various global markets, his leadership philosophy, as well as the impressive international growth of the company.   I feel a strong sense of responsibility and obligation working for a company that has potentially life-saving and life-transforming…

Singapore In an interview with Takeda’s President of Emerging Markets Business Unit, Giles Platford portrays a vitalized focus on emerging markets and explains why those countries are positioned as one of three key growth drivers for the company. With Takeda’s recently unveiled Access-to-Medicines (AtM) strategy, he also characterizes the role of…

Takeda Takeda Mexico’s José Manuel Caamaño  discusses Takeda’s impressive growth prospects in Mexico, patient-centricity, the reopening of their cutting-edge manufacturing plant in Naucalpan, and his vision to transform Takeda into one of the most prominent pharmaceutical companies in Mexico, with a strengthened focus on GI and oncology. Christophe Weber, Takeda’s CEO,…

Switzerland Dr. Othmar Pfannes, founder and CEO of Genedata, a bioinformatics company headquartered in Switzerland delivering enterprise software, data analysis consulting, and business-process analysis services to the life sciences community, reveals some insights into Genedata’s business strategy and how ultimately their mission is to contribute to reducing the costs of drug…

Pharma Meda Pharma Hungary GM Dr. Laszlo Gaspar describes how the strategic shift from Rx to OTC has allowed the company to experience year-on-year growth over the last eight years and increase annual revenues threefold. He further emphasizes the value of targeting medical promotion in securing a competitive positioning in several…

Pharma Takeda’s goal is to become a trusted and reliable partner in the healthcare system by better understanding patients’ needs. Aarnoud Overkamp, general manager of the Dutch subsidiary, shares his perspective on the challenges faced by the local healthcare system, the importance of Takeda-ism in the organization, and finding innovative ways…

Pharma By square mile, Puerto Rico has more post-secondary institutions than anywhere in the world. This concentration has led to the development of a number of college and university programs which produce world-class talent for the territory’s life sciences industry. From the manufacturing perspective, one of the leading institutes in Puerto…

Pharma Chris Juliam, Managing Director for Takeda Italy, shares the strategy the company is pursuing in the country, the effects market-access issues are having on innovators and patients, and what new products the company’s pipeline holds for the future. When we interviewed Takeda in 2009, you were ranked 20th in the…

pharma   The Thai pharmaceutical market is growing due to an aging, wealthier local population and a large medical tourism sector. International companies must however adapt their strategies to suit the Thai market; as must domestic concerns. With an estimated value of USD 4.5 billion, Thailand is Southeast Asia’s second largest…

Pharma Pedro Tejada of Right Way Environmental introduces the environmental and life science markets in Puerto Rico and elaborates on the challenges that the company faces. What were the main reasons for the establishment of Right Way Environmental? I have worked in the environmental field since 1983. In 1995, my wife and…

Takeda The Japan-based company is changing into a new Takeda. José Manuel Caamaño, general manager of Takeda Mexico, talks about the transformation process the company is going through to become a best-in-class organization. The company’s five-year aim is to be recognized as a best employer in Mexico keeping the values and…

Takeda Pharma GmbH Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player with a turnover of roughly €80 million, according to IMS figures. In primary care markets we focus on core therapeutic areas such as cardiovascular…